Trials / Completed
CompletedNCT00190619
Efficacy and Safety of Duloxetine
Efficacy and Safety of Duloxetine Compared With Placebo in Subjects Electing Surgery for Severe Pure Genuine Stress Incontinence
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 100 (planned)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- Female
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to monitor the long term safety and efficacy of duloxetine in the treatment of severe pure genuine stress incontinence.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Duloxetine | |
| DRUG | Placebo |
Timeline
- Start date
- 2001-05-01
- Completion
- 2006-05-01
- First posted
- 2005-09-19
- Last updated
- 2007-01-26
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT00190619. Inclusion in this directory is not an endorsement.